Category: data issues

Psychology journal to retract study claiming that people fear contagion less in the dark

As we’re fond of repeating, sunlight is the best disinfectant. Which doesn’t jibe with the findings in an eye-catching  2018 paper that found people were less fearful of catching a contagious illness if they were in a dark room or were wearing sunglasses.

Fortunately for us, although not for the researchers, we no longer have to live with the cognitive dissonance. The paper, the journal tells us, will be retracted for flaws in the data — which, thanks to the open sharing of data, quickly came to light.

The study, which appeared in May in Psychological Science, reported that: Continue reading Psychology journal to retract study claiming that people fear contagion less in the dark

Journals stamp expressions of concern on 15 papers from Anversa’s cardiac stem cell lab

Piero Anversa

More than four and a half years after questions were first raised about work in a cardiac stem cell lab at Harvard and the Brigham and Women’s Hospital, a year and a half after the Brigham and Partners Healthcare paid $10 million to settle allegations of fraud in the lab’s data, a month after Harvard the Brigham disclosed that they were calling for the retractions of more than 30 papers from the lab, and three weeks after the NIH paused a clinical trial based on the work, two leading journals have issued an expression of concern about 15 papers from the lab.

But expressions of concern are not retractions, of course. From the notice, in Circulation and Circulation Research, both of which are published by the American Heart Association: Continue reading Journals stamp expressions of concern on 15 papers from Anversa’s cardiac stem cell lab

In a first, U.S. CDC retracts, replaces study about suicide risk in farmers

In a first for the CDC, the agency’s premier scientific publication has retracted a 2016 article on suicide, five months after a news story pointed out serious errors in the paper.

The article, initially published as “Suicide Rates by Occupational Group — 17 States, 2012,” had purported to find that farmers were at particularly high risk of suicide. That result in particular caught the attention of a website called The New Food Economy (TNFE), which last June called out what it said were errors in the CDC’s analysis. And on June 29, the journal, the Morbidity and Mortality Weekly Report (MMWR), issued a reader’s note.

As TNFE wrote, the crux of the mistake involves the misclassification of farmer suicides in a way that significantly inflated the rate of these events — errors the website said it first raised with the CDC in April 2018: Continue reading In a first, U.S. CDC retracts, replaces study about suicide risk in farmers

Data mishap forces retraction of paper on gun laws, domestic killings

The authors of a 2018 paper on the effects of gun laws on domestic violence have retracted the article after discovering errors in their analysis and replaced it with a clean version. The new study shows that some gun laws — particularly ones that keep firearms out of the hands of violent offenders, even if their offenses don’t involve domestic assaults — do seem to reduce the incidence of domestic killings.

The paper, which appeared last November in the American Journal of Epidemiology and received some press coverage, including this piece in the New York Times, looked specifically at whether laws that keep guns away from people convicted of violent crimes beyond domestic abuse reduce the number of intimate partner homicides. It also considered the effect of laws that covered dating partners and not simply spouses or former spouses. The first author is April Zeoli, of Michigan State University. Zeoli has published other papers on the topic and delivered a TEDMED talk on it as well.

According to the abstract of the article: Continue reading Data mishap forces retraction of paper on gun laws, domestic killings

Caveat scriptor: How a journal editor unraveled the mystery of the overlapping bad data

John Loadsman

Caveat scriptor—writer beware.

That’s the moral of a recent editorial in the Saudi Journal of Anesthesia, prompted by the retraction in that journal of a 2014 paper with bum data.

The editorial was written by John Loadsman, an anesthesiologist in Sydney, Australia, and editor of the journal Anaesthesia and Intensive Care, who played a role in the retraction. Here’s how.

According to Loadsman, he was considering an article for his journal — a meta-analysis of previously published findings. On inspection, he he noticed that some of the studies cited in the meta-analysis were potentially problematic, including Continue reading Caveat scriptor: How a journal editor unraveled the mystery of the overlapping bad data

As China cracks down on faked drug trial data, US FDA abandons disclosure rule

The FDA has walked away from a 2010 rule that would have forced drug makers to disclose fabricated data to regulators.

As Bloomberg Law reported last week, the FDA has withdrawn the proposed rule, “Reporting Information Regarding Falsification of Data,” which would Continue reading As China cracks down on faked drug trial data, US FDA abandons disclosure rule

Caught Our Notice: Gorilla paper in the mist? Journal flags ape hormone paper

Title: Biologically validating the measurement of oxytocin in western lowland gorilla (Gorilla gorilla gorilla) urine and saliva using a commercial enzyme immunoassay

What Caught Our Attention: Quite frankly, anything with “gorilla gorilla gorilla” in the title will catch our eye, even if it is just the scientific name of the western lowland gorilla. In this case, the journal issued an expression of concern over an “unintended discrepancy” that may have affected the paper, which validates the use of a tool to measure oxytocin in the apes’ urine and saliva. The authors voluntarily notified the editors of Primate of the potential issue, and the journal issued an Expression of Concern only one month after the article was published — which is pretty fast for a notice, although not a record (see this one, issued six days after publication).

We contacted the editor, who told us:

Continue reading Caught Our Notice: Gorilla paper in the mist? Journal flags ape hormone paper

Paper used to support WHO guidelines on preventing infections “has no scientific validity”

A surgery journal retracted a 2014 paper last month after discovering that the study has “no scientific validity.”

Mario Schietroma and his coauthors, based at the University of L’Aquila in Italy, reported that giving patients high concentrations of oxygen during and after colorectal surgery significantly reduced their risk of infections. Although the authors reported significant p-values, the retraction notice states that, “upon recalculation, no p-values were close to significant.” The University of L’Aquila told Retraction Watch it is investigating, but did not provide details. Continue reading Paper used to support WHO guidelines on preventing infections “has no scientific validity”

Cancer biologist retracts five papers

Samson Jacob

A cancer researcher based at The Ohio State University has retracted five papers from one journal, citing concerns about figures.

The notices for all five papers state the Journal of Biological Chemistry raised questions about some figures, and the authors were not able to supply raw data in all instances. Four of the notices say the authors offered to submit data from repeat experiments and corrected figures, which the journal declined.

According to Kaoru Sakabe, data integrity manager at JBC, the authors “agreed to withdraw these articles after we declined their offers.”

Continue reading Cancer biologist retracts five papers

Child took wrong compound for over a year after “communication error”

Credit: Steven Depolo, Flickr

A journal is retracting a paper after it discovered researchers gave a child the wrong supplement for more than a year.

Rhiannon Bugno, managing editor for Biological Psychiatry, told Retraction Watch the mix-up did not put the patient at risk. However, the mistake was enough for the journal’s editor, John Krystal, of Yale University, to request the retraction of a 2016 paper describing the young girl’s experience taking the compound,“Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement.”

Originally published June 17, 2016, the paper was retracted Jan. 15. Led by corresponding author Xavier Altafaj, of the University of Barcelona (UB) and Bellvitge Biomedical Research Institute (IDIBELL), researchers described using an amino acid, D-serine, to treat a child with a rare genetic disorder that affects neurons.

According to the notice, the researchers did use D-serine in lab work used as proof-of-concept; however, when it came time to try it in the patient, as a result of a “communication error:”

Continue reading Child took wrong compound for over a year after “communication error”